Non-traumatic topical treatment of onychomycosis with urea associated with bifonazole. 1991

J M Torres-Rodríguez, and N Madrenys, and M C Nicolás
Department of Microbiology, Autonomous University of Barcelona, Spain.

The need for a topical, non-traumatic treatment for onychomycoses of different etiologies has led to a search for increased effectiveness by associating products which have different and complementary effects, as is the case of the keratoplastic and broad-spectrum antifungal agents. Using a 40% urea and 1% bifonazole cream, 42 nails with fungal infections (28 patients) were treated until the infected area softened and could be removed, after which 1% bifonazole cream was applied. After a 6 to 12 month follow-up, the treatment success rate has been 93.8% for fingernails and 88.5% for toenails. The cultures became negative within 3 weeks after starting therapy with urea and bifonazole. Tolerance was good and it was not necessary to stop treatment in any patient. The topical, combined use of urea and bifonazole is a good alternative in the treatment of onychomycoses of different etiologies, provided that strict compliance by the patient is ensured, and that the application instructions are followed correctly.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J M Torres-Rodríguez, and N Madrenys, and M C Nicolás
January 1988, Annals of the New York Academy of Sciences,
J M Torres-Rodríguez, and N Madrenys, and M C Nicolás
January 2000, Pediatric dermatology,
J M Torres-Rodríguez, and N Madrenys, and M C Nicolás
April 1990, Mycoses,
J M Torres-Rodríguez, and N Madrenys, and M C Nicolás
February 1992, Harefuah,
J M Torres-Rodríguez, and N Madrenys, and M C Nicolás
January 1998, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology,
J M Torres-Rodríguez, and N Madrenys, and M C Nicolás
January 1992, Dermatology (Basel, Switzerland),
J M Torres-Rodríguez, and N Madrenys, and M C Nicolás
July 1995, International journal of dermatology,
J M Torres-Rodríguez, and N Madrenys, and M C Nicolás
May 1988, Clinical and experimental dermatology,
Copied contents to your clipboard!